beta -Amyloid peptide-induced apoptosis regulated by a novel protein containing a g protein activation module

Degeneration of neurons in Alzheimer's disease is mediated by beta-amyloid peptide by diverse mechanisms, which include a putative apoptotic component stimulated by unidentified signaling events. This report describes a novel beta-amyloid peptide-binding protein (denoted BBP) containing a G pro...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of biological chemistry Vol. 276; no. 22; pp. 18748 - 18756
Main Authors Kajkowski, E M, Lo, C F, Ning, X, Walker, S, Sofia, H J, Wang, W, Edris, W, Chanda, P, Wagner, E, Vile, S, Ryan, K, McHendry-Rinde, B, Smith, S C, Wood, A, Rhodes, K J, Kennedy, J D, Bard, J, Jacobsen, J S, Ozenberger, B A
Format Journal Article
LanguageEnglish
Published United States 01.06.2001
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Degeneration of neurons in Alzheimer's disease is mediated by beta-amyloid peptide by diverse mechanisms, which include a putative apoptotic component stimulated by unidentified signaling events. This report describes a novel beta-amyloid peptide-binding protein (denoted BBP) containing a G protein-coupling module. BBP is one member of a family of three proteins containing this conserved structure. The BBP subtype bound human beta-amyloid peptide in vitro with high affinity and specificity. Expression of BBP in cell culture induced caspase-dependent vulnerability to beta-amyloid peptide toxicity. Expression of a signaling-deficient dominant negative BBP mutant suppressed sensitivity of human Ntera-2 neurons to beta-amyloid peptide mediated toxicity. These findings suggest that BBP is a target of neurotoxic beta-amyloid peptide and provide new insight into the molecular pathophysiology of Alzheimer's disease.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0021-9258
1083-351X
DOI:10.1074/jbc.M011161200